Physician profile
Les Burns
NPI 1528092608
$2,732.77
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $439 · 2021: $500 · 2022: $362 · 2023: $550 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.32 |
| Education | $153.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $342.48 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Celularity INC. | $300.00 | 2019 | |
| Mayne Pharma Commercial LLC | $251.68 | 2021-2023 | |
| Exeltis, USA INC. | $246.90 | 2019-2024 | Slynd, Tyblume |
| Avion Pharmaceuticals | $221.46 | 2019-2023 | Balcoltra |
| Astellas Pharma US INC | $186.69 | 2023-2024 | Veozah |
| Evofem Biosciences, INC. | $144.37 | 2021-2024 | Phexxi |
| Therapeuticsmd, INC. | $138.37 | 2019-2022 | |
| Pfizer INC. | $126.09 | 2019-2024 | |
| Lupin INC. | $111.99 | 2019-2021 | |
| Glaxosmithkline, LLC. | $98.54 | 2019-2022 | |
| Roche Diagnostics Corporation | $90.78 | 2019-2021 | |
| Millicent US INC | $85.13 | 2023-2024 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $68.02 | 2020-2023 | Novasure |
| Exact Sciences Corporation | $46.77 | 2023-2024 | Cologuard Collection Kit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $41.54 | 2019-2020 | |
| Alydia Health | $40.22 | 2021 | |
| Medicem INC. | $28.51 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $27.47 | 2019 | |
| Agile Therapeutics, INC. | $26.95 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $20.12 | 2023 | Vivjoa |
| Meditrina | $19.43 | 2023 | |
| Myovant Sciences INC. | $17.87 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.90 | 2019 | |
| Coopersurgical, INC. | $12.63 | 2019 | |
| Daiichi Sankyo INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Les Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.